IP Library Granted Patent US 8,109,866
Granted Patent B2
US 8,109,866 · App. 12/473,747 · Granted Feb 7, 2012

Method and apparatus for prolapse repair

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,109,866
App. No.
12/473,747
Granted
Feb 7, 2012
Kind
B2
Abstract

A pelvic implant having a central support portion, and a plurality of extension members, is provided. The extension members can be positioned or extend from the central support portion in opposing pairs. The extension members are generally attached to the central support portion at respective junctions (e.g., via rivets), and sheaths or covers can be employed to cover at least a length or portion of the extension members. Further, one or more spanning members can extend from a first of the opposed and paired extensions to the opposing extension, e.g., under or across the central portion and the respective junctions to provide additional tensile strength for the implant during deployment or implantation.

Claims (31)

1. A surgical implant to provide support within the pelvic region of a patient, comprising:

a support portion;

a plurality of extension portions operatively extending from the support portion at support junctions, with the plurality of extension portions positioned in opposing pairs; and

at least one spanning member operatively extending from a first of the extension portions, across the support portion, to an opposing second of the extension portions to assist in increasing the strength of the implant.

2. The implant of claim 1 , wherein the implant is selected from a group consisting of: a urethral support, a rectal support, and a vaginal prolapse support.

3. The implant of claim 1 , wherein the support junctions include a rivet.

4. The implant of claim 3 , wherein the rivet is a polymeric rivet.

5. The implant of claim 1 , wherein the support portion comprises biologic material and the extension portions comprise synthetic mesh material.

6. The implant of claim 1 , wherein the at least one spanning member is a polymeric material.

7. The implant of claim 6 , wherein the polymeric material is a low density polyethylene material.

8. The implant of claim 1 , further including a plurality of sheaths, with each sheath covering a portion of a respective extension portion.

9. The implant of claim 8 , wherein a first end of the at least one spanning member extends from a first sheath and a second end of the at least one spanning member is bonded to a second opposing sheath.

10. A surgical implant to provide support within the pelvic region of a patient, comprising:

a support portion;

first and second extension members operatively extending from the support portion at respective first and second support junctions, with the first and second extension members being positioned in opposition to one another with the support portion disposed there between; and

at least one spanning member operatively extending from the first extension member, under the support portion and the first and second support junctions, to the second extension member to assist in increasing the strength of the implant.

11. The implant of claim 10 , wherein the implant is selected from a group consisting of: a urethral support, a rectal support, and a vaginal prolapse support.

12. The implant of claim 10 , wherein at least one of the first and second support junctions includes a rivet.

13. The implant of claim 12 , wherein the rivet is a polymeric rivet.

14. The implant of claim 10 , wherein the support portion comprises biologic material and the extension members comprise synthetic mesh material.

15. The implant of claim 10 , wherein the at least one spanning member comprises a low density polyethylene material.

16. The implant of claim 10 , further including a first sheath covering a portion of the first extension member, and a second sheath covering a portion of the second extension member.

17. The implant of claim 10 , wherein a first end of the at least one spanning member extends from the first sheath and a second end of the at least one spanning member is bonded to the opposing second sheath.

18. The implant of claim 17 , wherein the second end of the at least one spanning member is heat bonded to the opposing second sheath.

19. The implant of claim 17 , wherein the second end of the at least one spanning member is heat bonded to an interior surface of the opposing sheath.

20. A method of implanting and deploying an implant in the pelvic region of a patient, comprising:

providing an implant having a central support portion and at least first and second extension members operatively extending from the central support portion in opposition to one another, the first and second extension members covered at least partially by first and second sheaths, with the implant further having at least one spanning member operatively extending from the first sheath, under the central support portion, to the second sheath to assist in increasing the strength of the implant;

introducing the implant within the pelvic region of the patient with one or more introducer tools;

securing the implant to tissue within the pelvic region of the patient;

cutting a portion of the second sheath and a portion of the spanning member extending from the second sheath; and

removing the first sheath with a portion of the spanning member extending therefrom.

Assignments (17)
SECURITY INTEREST Recorded Jul 22, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068469/0001 →
SECURITY INTEREST Recorded Jul 19, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068461/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2024
From: ENDO USA, INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067245/0492 →
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0491 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2024
From: ASTORA WOMEN’S HEALTH, LLC
To: ENDO USA, INC.
Reel/Frame 067202/0768 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0728. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Apr 21, 2017
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 042308/0630 →
CHANGE OF NAME Recorded Jan 18, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037551/0749 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037551/0626 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0728 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
SECURITY AGREEMENT Recorded Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2009
From: BOUCHIER, MARK S.; LUND, ROBERT E.; GOHMAN, JAMES A.; LECHNER-RIEHLE, JEFFREY A.
To: AMS RESEARCH CORPORATION
Reel/Frame 022863/0120 →